Plasma Resilience: Europe's Lifeline
Medicines made from human plasma are essential for developing therapies for various conditions, including rare inherited disorders and immunodeficiencies.
Human plasma, accounting for 55% of our blood, is a golden, protein-rich liquid that is vital for these therapies. However, Europe's supply chain of this valuable resource is vulnerable due to its reliance on human donations.
- Over 12 million people across Europe donate plasma annually.
- Donations are governed by rigorous safety standards set by EU Member States and international organizations.
- Despite this, nearly 40% of plasma used to make medicines for Europe is imported from the United States.
Each year, more than 12 million people across Europe donate plasma through a process governed by rigorous safety standards.
The Plasma Protein Therapeutics Association (PPTA) and the International Quality Plasma Program (IQPP) oversee the process, ensuring strict safety standards are met.
Author's summary: Europe relies heavily on human plasma donations.
More News
- Republican justices appear poised to destroy what’s left of the Voting Rights Act
- Why Every Jurisdiction Should Have Automated Court Reminders - R Street Institute
- YouTube Down for More Than a Hundred Thousand Users, Downdetector Shows
- Budget battles and bureaucracy plague inland waterways infrastructure
- Diane Keaton cause of death revealed
- Two decades after beating cancer, Durga Devi’s life becomes a story of hope
- Trade unions demand end to attacks on overseas workforce
- Armenians in Jerusalem and the dilemma of Israel's recognition of the Armenian Genocide
- Mon BOE: Summer Sizzler, Avalanche to continue next year after all - Dominion Post
- Taylor Thomson: The Revenue Leader Who Refuses to Say It's Not in Salesforce, It Doesn't Exist - CEOWORLD magazine